Daniel A. Ozaki

1.5k total citations
14 papers, 849 citations indexed

About

Daniel A. Ozaki is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Daniel A. Ozaki has authored 14 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Daniel A. Ozaki's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Congenital heart defects research (3 papers). Daniel A. Ozaki is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Congenital heart defects research (3 papers). Daniel A. Ozaki collaborates with scholars based in United States, United Kingdom and Germany. Daniel A. Ozaki's co-authors include Marcella Sarzotti, Marcella Sarzotti‐Kelsoe, David C. Montefiori, Kelli Greene, Christopher A. Todd, Hongmei Gao, Robert T. Bailer, John R. Mascola, Esra Abacı Türk and Miroslawa Bilska and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Daniel A. Ozaki

13 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel A. Ozaki United States	12	393	327	243	199	168	14	849
Zoltán Bánki Austria	20	670 1.7×	299 0.9×	171 0.7×	195 1.0×	148 0.9×	48	1.0k
Peter Kuebler United States	15	418 1.1×	255 0.8×	250 1.0×	176 0.9×	97 0.6×	32	995
Mar Naranjo‐Gómez Spain	18	868 2.2×	260 0.8×	430 1.8×	212 1.1×	161 1.0×	33	1.4k
J C Gluckman France	17	380 1.0×	328 1.0×	137 0.6×	162 0.8×	119 0.7×	37	811
Smita Ghanekar United States	18	875 2.2×	237 0.7×	272 1.1×	101 0.5×	310 1.8×	27	1.3k
Daniele Accapezzato Italy	19	987 2.5×	134 0.4×	251 1.0×	160 0.8×	428 2.5×	47	1.6k
Juana Gil Spain	17	498 1.3×	141 0.4×	186 0.8×	84 0.4×	129 0.8×	38	861
Peter van Swieten Netherlands	19	247 0.6×	205 0.6×	126 0.5×	213 1.1×	172 1.0×	30	1.3k
T K Hart United States	13	412 1.0×	526 1.6×	169 0.7×	315 1.6×	183 1.1×	23	970
Katsuya Fujimoto Japan	17	383 1.0×	128 0.4×	103 0.4×	179 0.9×	274 1.6×	58	1.2k

Countries citing papers authored by Daniel A. Ozaki

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Ozaki more than expected).

Fields of papers citing papers by Daniel A. Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Ozaki. The network helps show where Daniel A. Ozaki may publish in the future.

Co-authorship network of co-authors of Daniel A. Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Ozaki. A scholar is included among the top collaborators of Daniel A. Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Ozaki. Daniel A. Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dennison, S. Moses, Kelly E. Seaton, Sheetij Dutta, et al.. (2018). Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens. The Journal of Immunology. 201(4). 1315–1326. 24 indexed citations

Germann, Anja, Marcella Sarzotti‐Kelsoe, Daniel A. Ozaki, et al.. (2018). Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks. PLoS ONE. 13(1). e0190669–e0190669. 1 indexed citations

Sarzotti‐Kelsoe, Marcella, Robert T. Bailer, Esra Abacı Türk, et al.. (2013). Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. Journal of Immunological Methods. 409. 131–146. 290 indexed citations

Koch, Stefanie, Marcella Sarzotti‐Kelsoe, Daniel A. Ozaki, et al.. (2012). An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials. PLoS ONE. 7(12). e51715–e51715. 13 indexed citations

Ozaki, Daniel A., Hongmei Gao, Christopher A. Todd, et al.. (2012). International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials. PLoS ONE. 7(1). e30963–e30963. 31 indexed citations

Todd, Christopher A., Kelli Greene, Xuesong Yu, et al.. (2011). Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. Journal of Immunological Methods. 375(1-2). 57–67. 50 indexed citations

Sarzotti‐Kelsoe, Marcella, Josephine H. Cox, Thomas N. Denny, et al.. (2009). Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials. PLoS Medicine. 6(5). e1000067–e1000067. 34 indexed citations

Sarzotti‐Kelsoe, Marcella, Josephine H. Cox, Thomas N. Denny, et al.. (2009). P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials. Retrovirology. 6(S3). 3 indexed citations

Fadel, Shaza A., Lindsay G. Cowell, Shui Cao, et al.. (2006). Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. International Immunology. 18(2). 249–257. 18 indexed citations

10.

Markert, M. Louise, Jie Li, Marcella Sarzotti, et al.. (2004). Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. Journal of Allergy and Clinical Immunology. 113(4). 734–741. 104 indexed citations

11.

Markert, M. Louise, Jie Li, Marcella Sarzotti, et al.. (2004). Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 104(8). 2574–2581. 69 indexed citations

12.

Sarzotti, Marcella, Dhavalkumar D. Patel, Xiaojing Li, et al.. (2003). T Cell Repertoire Development in Humans with SCID After Nonablative Allogeneic Marrow Transplantation. The Journal of Immunology. 170(5). 2711–2718. 86 indexed citations

13.

Markert, M. Louise, Marcella Sarzotti, Daniel A. Ozaki, et al.. (2003). Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 102(3). 1121–1130. 103 indexed citations

14.

Fadel, Shaza A., Daniel A. Ozaki, & Marcella Sarzotti. (2002). Enhanced Type 1 Immunity After Secondary Viral Challenge in Mice Primed as Neonates. The Journal of Immunology. 169(6). 3293–3300. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact